Cubist Systematic Strategies’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $38.5M | Buy |
458,259
+453,859
| +10,315% | +$37.4M | 0.18% | 114 |
|
|
2025
Q2 | $348K | Buy |
+4,400
| New | +$350K | ﹤0.01% | 2404 |
|
|
2025
Q1 | – | Sell |
-23,906
| Closed | -$2.23M | – | 3269 |
|
|
2024
Q4 | $2.38M | Sell |
23,906
-334,086
| -93% | -$34.4M | 0.01% | 1250 |
|
|
2024
Q3 | $40.7M | Buy |
357,992
+37,052
| +12% | +$4.4M | 0.25% | 58 |
|
|
2024
Q2 | $39.7M | Buy |
320,940
+276,246
| +618% | +$35.6M | 0.27% | 42 |
|
|
2024
Q1 | $5.9M | Buy |
+44,694
| New | +$5.51M | 0.03% | 857 |
|
|
2023
Q4 | – | Sell |
-302,448
| Closed | -$31.4M | – | 3902 |
|
|
2023
Q3 | $31.1M | Buy |
+302,448
| New | +$32.6M | 0.23% | 53 |
|
|
2023
Q2 | – | Sell |
-23,243
| Closed | -$2.64M | – | 4006 |
|
|
2023
Q1 | $2.47M | Sell |
23,243
-71,826
| -76% | -$7.75M | 0.02% | 1503 |
|
|
2022
Q4 | $10.5M | Sell |
95,069
-51,045
| -35% | -$5.22M | 0.06% | 445 |
|
|
2022
Q3 | $12.6M | Sell |
146,114
-104,873
| -42% | -$9.36M | 0.07% | 347 |
|
|
2022
Q2 | $22.9M | Buy |
250,987
+42,962
| +21% | +$3.81M | 0.14% | 89 |
|
|
2022
Q1 | $17.1M | Buy |
208,025
+11,249
| +6% | +$887K | 0.14% | 111 |
|
|
2021
Q4 | $15.1M | Buy |
196,776
+166,808
| +557% | +$13.3M | 0.14% | 96 |
|
|
2021
Q3 | $2.25M | Sell |
29,968
-9,224
| -24% | -$702K | 0.03% | 933 |
|
|
2021
Q2 | $3.05M | Sell |
39,192
-365,384
| -90% | -$27.2M | 0.03% | 821 |
|
|
2021
Q1 | $29.8M | Buy |
404,576
+93,241
| +30% | +$6.88M | 0.38% | 11 |
|
|
2020
Q4 | $24.3M | Buy |
311,335
+78,557
| +34% | +$6.01M | 0.33% | 19 |
|
|
2020
Q3 | $18.4M | Buy |
232,778
+172,523
| +286% | +$13.5M | 0.27% | 36 |
|
|
2020
Q2 | $4.45M | Sell |
60,255
-192,033
| -76% | -$14.5M | 0.08% | 403 |
|
|
2020
Q1 | $18.5M | Buy |
252,288
+192,499
| +322% | +$15.1M | 0.5% | 10 |
|
|
2019
Q4 | $5.19M | Sell |
59,789
-52,317
| -47% | -$4.3M | 0.1% | 296 |
|
|
2019
Q3 | $9.01M | Sell |
112,106
-92,838
| -45% | -$7.44M | 0.18% | 129 |
|
|
2019
Q2 | $16.4M | Buy |
204,944
+200,611
| +4,630% | +$15.4M | 0.3% | 41 |
|
|
2019
Q1 | $344K | Sell |
4,333
-2,797
| -39% | -$209K | 0.01% | 1424 |
|
|
2018
Q4 | $520K | Sell |
7,130
-33,880
| -83% | -$2.39M | 0.02% | 940 |
|
|
2018
Q3 | $2.78M | Sell |
41,010
-2,211
| -5% | -$141K | 0.15% | 127 |
|
|
2018
Q2 | $2.5M | Sell |
43,221
-4,546
| -10% | -$256K | 0.13% | 191 |
|
|
2018
Q1 | $2.48M | Sell |
47,767
-25,724
| -35% | -$1.39M | 0.15% | 161 |
|
|
2017
Q4 | $3.95M | Buy |
73,491
+8,075
| +12% | +$448K | 0.21% | 74 |
|
|
2017
Q3 | $4M | Buy |
65,416
+10,375
| +19% | +$629K | 0.22% | 60 |
|
|
2017
Q2 | $3.37M | Buy |
55,041
+38,587
| +235% | +$2.35M | 0.22% | 79 |
|
|
2017
Q1 | $998K | Sell |
16,454
-75,194
| -82% | -$4.56M | 0.07% | 340 |
|
|
2016
Q4 | $5.15M | Buy |
91,648
+78,024
| +573% | +$4.57M | 0.41% | 17 |
|
|
2016
Q3 | $811K | Sell |
13,624
-35,962
| -73% | -$2.1M | 0.05% | 498 |
|
|
2016
Q2 | $2.73M | Sell |
49,586
-9,851
| -17% | -$524K | 0.16% | 129 |
|
|
2016
Q1 | $3M | Sell |
59,437
-28,656
| -33% | -$1.4M | 0.17% | 123 |
|
|
2015
Q4 | $4.44M | Buy |
88,093
+83,597
| +1,859% | +$4.21M | 0.26% | 59 |
|
|
2015
Q3 | $212K | Sell |
4,496
-122,370
| -96% | -$6.5M | 0.01% | 1445 |
|
|
2015
Q2 | $6.89M | Buy |
126,866
+82,242
| +184% | +$4.61M | 0.34% | 35 |
|
|
2015
Q1 | $2.45M | Sell |
44,624
-72,257
| -62% | -$4.09M | 0.12% | 211 |
|
|
2014
Q4 | $6.33M | Sell |
116,881
-58,854
| -33% | -$3.28M | 0.34% | 29 |
|
|
2014
Q3 | $9.94M | Buy |
175,735
+82,750
| +89% | +$4.65M | 0.61% | 5 |
|
|
2014
Q2 | $5.13M | Buy |
+92,985
| New | +$5.07M | 0.31% | 46 |
|
Other funds holding MRK
Cubist Systematic Strategies's MRK Position: Q3 2025 in Review
Cubist Systematic Strategies increased its Merck (MRK) stake by 10,315% in Q3 2025, buying an estimated $37.4M and bringing the position to 458,259 shares worth $38.5M. The position accounts for 0.18% of the portfolio, ranked #114.
Cubist Systematic Strategies first reported a position in MRK in Q2 2014 and has held it in 43 quarters since. The position peaked at $40.7M in Q3 2024. 3,309 funds tracked by Wall St. Rank hold MRK as of Q3 2025.
- Cubist Systematic Strategies held 458,259 shares of Merck worth $38.5M as of Q3 2025.
- Cubist Systematic Strategies bought 453,859 Merck shares in Q3 2025, an estimated $37.4M.
- Merck made up 0.18% of Cubist Systematic Strategies's portfolio in Q3 2025, its #114 holding.
- Cubist Systematic Strategies first reported a position in Merck in Q2 2014 and has held it in 43 quarters since.
- Cubist Systematic Strategies's Merck position peaked at $40.7M in Q3 2024.
- 3,309 funds tracked by Wall St. Rank held Merck as of Q3 2025.
Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.